Scott Aho Email & Phone Number | Vice President of Business Development

Scott Aho

Vice President of Business Development
United States

*50 free lookup(s) per month.

No credit card required.

Scott Aho’s Email saho@oraclinical.com

Scott Aho’s Phone Numbers +1-978-685-****

Get SCOTT’s Phone Number (For Free)

Social Media

Scott Aho’s Location United States

Scott Aho’s Current Industry Ora, Inc.

Not the Scott Aho you were looking for?

Find accurate emails & phone numbers for over 700M professionals.

Work Experience

Ora, Inc.

Vice President of Business Development

2023-02-01 - Present

Javara

Senior Director, Emerging Healthcare Partnerships

2020-12-01 - 2023-02-01

Aerie Pharmaceuticals

Mountains, Pacific Northwest & Hawaii Sales Manager

2018-03-01 - 2020-12-01

Synergy Pharmaceuticals Inc. (NASDAQ: SGYP)

Regional Business Director

2016-10-01 - 2018-03-01

TearLab Corporation

Global Director, Performance Development

2014-09-01 - 2016-10-01

ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant)

District Sales Manager

2010-01-01 - 2012-06-01

Altana Pharma

Sales Representative

2003-06-01 - 2006-11-01

Talx Uc Express

District Manager

1998-06-01 - 2003-06-01

The Gibbens Co.

Sr Hearings Rep

1994-01-01 - 1998-01-01

Skills

allergy dry eye retina antiinfective antiinflammatory glaucoma medical devices drug delivery

Languages

FAQ About Scott Aho

Scott Aho is located at
United States

Scott Aho is a Vice President of Business Development

Scott Aho currently works in the Ora, Inc. |

Scott Aho speaks the following languages: English

Scott Aho has prior
experience in the following industries:
Javara | Aerie Pharmaceuticals | Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) | TearLab Corporation | ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) | Altana Pharma | Talx Uc Express | The Gibbens Co.

Scott Aho has the following professional experience:
Ora, Inc. | Javara | Aerie Pharmaceuticals | Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) | TearLab Corporation | ISTA Pharmaceuticals (Products now under Bausch + Lomb, which was acquired by Valeant) | Altana Pharma | Talx Uc Express | The Gibbens Co.